Home Health TB vax linked to lower risk of contracting Covid-19

TB vax linked to lower risk of contracting Covid-19

New research adds to a growing body of evidence that Bacillus Calmette-Guerin (BCG), a vaccine for tuberculosis (TB), is associated with a reduced possibility of contracting the Covid-19 virus.

In the new study, published in The Journal of Clinical Investigation, the research team tested the blood of more than 6,000 healthcare workers for evidence of antibodies to SARS-CoV-2, the virus that causes Covid-19, and also asked them about their medical and vaccination histories.

They found that workers who had received BCG vaccinations in the past-nearly 30 percent of those studied-were significantly less likely to test positive for SARS-CoV-2 antibodies in their blood or to report having had infections with coronavirus or associated symptoms over the prior six months than those who had not received BCG.

These effects were not related to whether workers had received meningococcal, pneumococcal, or influenza vaccinations. The reasons for the lower SARS-CoV-2 antibody levels in the BCG group were not clear, according to the researchers.

“It appears that BCG-vaccinated individuals either may have been less sick and therefore produced fewer anti-SARS-CoV-2 antibodies, or they may have mounted a more efficient cellular immune response against the virus,” said study author Moshe Arditi, Cedars-Sinai Medical Centre in the US.

“We were interested in studying the BCG vaccine because it has long been known to have a general protective effect against a range of bacterial and viral diseases other than TB, including neonatal sepsis and respiratory infections,” Arditi added.

In the study, the lower antibody levels in the BCG group persisted despite the fact that these individuals had higher frequencies of hypertension, diabetes, cardiovascular diseases, and COPD.

“Given our findings, we believe that large, randomized clinical trials are urgently needed to confirm whether BCG vaccination can induce a protective effect against SARS-CoV2 infection,” said study author Susan Cheng from Cedars-Sinai.

Earlier in October, as part of a large-scale global trial, scientists in Britain had launched a study to test if the widely-used Bacillus Calmette-Guerin (BCG) vaccine could help protect people against Covid-19.

Also, a study that appeared in the pre-print repository medRxiv, found that the TB vaccine could be a potential new tool in the fight against the Covid-19 disease.

Most Popular

Black Friday sale logs $9bn in US, smartphones bring in $3.6bn

US consumers spent $9 billion online during the Black Friday sale, up by 21.6 percent on a year ago. Smartphones alone accounted for $3.6...

Addition of new servers led to massive outage last week: AWS

The addition of new servers to the network triggered the massive outage of Amazon Web Services (AWS) last week, affecting several websites and apps,...

Djokovic & Nadal to finish inside top 2 for third straight year

Novak Djokovic is set to equal Pete Sampras' record with a sixth year-end No. 1 finish when the year-end rankings are officially released on...

Samantha has posted there is no shoot

Maldives is the new holiday destination for the film personalities. We have seen many heroines flying to this beautiful place to take some time...
FMIM Ad